������Ƶ

Professor Low Teck Yew

Professor Low Teck Yew brings over two decades of research experience in proteomics, biological mass spectrometry, and proteogenomics. He is internationally recognized for his high-impact publications, invited talks at global conferences, and leadership roles in prominent scientific organizations. Through active involvement in interdisciplinary projects and a strong international network, he contributes significantly to global proteomics initiatives. Beyond his research, Professor Low is a passionate mentor and educator who fosters critical thinking and intellectual curiosity through innovative teaching methods. His leadership in AOHUPO and HUPO plays a key role in identifying and nurturing the next generation of international research talent.

Professor Felicia Chung Fei Lei

Professor Felicia Chung obtained her PhD in Biotechnology at Monash University in 2014. She then joined International Medical University (Malaysia) as a postdoctoral fellow and later as a lecturer, researching cancer cell biology, cancer stem cells, and drug repurposing. In 2017, she received a postdoctoral fellowship from the International Agency for Research on Cancer (France), the specialized cancer agency of the World Health Organization, where she joined the Mechanisms of Carcinogenesis section. She investigated mechanisms of epigenome stability, epigenetic biomarkers of cancer, and the impact of genetic alterations on the epigenome. Following the completion of the fellowship, she continued her research at the same agency in the capacity of postdoctoral scientist until her return to Malaysia in 2021. Her current research interests lie in cancer mutational signatures, intratumor heterogeneity, and the epigenetic mechanisms of cancer immune evasion.

Associate Professor Dr Yow Yoon Yen

Assoc. Prof. Dr. Yow is an algae biotechnologist and her research focuses on the discovery and development of new compounds from algae as nutraceutical candidates in the prevention of neurodegenerative diseases. Additionally, she is working on the beneficial effects of algae in cosmeceuticals and its anti-microbial and anti-cancer properties. She is also interested in the study of molecular phylogenetics and genetic diversity of algae, and invasive Pomacea apple snails.

The high value of algae and their products has made them an economically important natural resource in Malaysia. To date, a total of 386 specific and intraspecific taxa have been recorded in Malaysia. A number of these algae have been proven to contain natural compounds of anti-ulcerogenic, anti-inflammatory, anti-microbial, anti-neurodegenerative and gastroprotective properties, and serve as a promising antioxidant, chemotherapeutic, and anti-diabetic agents.

In line with ������Ƶ University’s commitment to the United Nations Sustainable Development Goals (UNSDGs), she looks forward to discovering how algae play a role in the SDGs with the aim to promote well-being for all.

��

Associate Professor Dr Wu Yuan Seng

Dr Wu graduated with first class and Vice Chancellor Award for his Bachelor’s degree. He then completed his PhD in Cancer Pharmacology and Therapeutics at the Department of Pharmacology, Faculty of Medicine, University of Malaya. He was then completed his short-term research fellow in cancer research at the School of Pharmacy, Monash University Malaysia in collaboration with the School of Bioscience, University of Nottingham Malaysia. He is now joining the Department of Biomedical Sciences, School of Medical and Life Sciences, ������Ƶ University. His research interests lie in searching for potential anticancer and antiviral agents and understanding their associated molecular mechanism(s), as well as developing efficient drug delivery or targeting system to cancer cells or virus-infected cells.

Associate Professor Dr Chew Jactty

Associate Professor Dr Jactty Chew obtained her BSc (Hons) in Biotechnology from Monash University, Malaysia before pursuing her PhD in Dentistry at the University of Adelaide, Australia. Her postgraduate project investigated the biofilm formation of an oral pathogen, Fusobacterium nucleatum, implicated in periodontal diseases. Upon completion, she worked as an Associate Lecturer in the School of Dentistry at the University of Adelaide. She joined ������Ƶ University in 2012 as a Lecturer and held the BSc (Hons) Medical Biotechnology Programme Chair position until 2015. Her primary research interest areas include antibiotic resistance, bacterial pathogenesis, antibacterial agents and the Malayan sun bear population genetics. She has received various research grants from different funding agencies including the Australian Dental Research Association, ������Ƶ University Internal Grant Scheme and the International Bear Association. She works closely with infectious disease physicians, paediatricians and sun bear conservation experts on her research projects. At the moment, she is supervising both undergraduate and postgraduate students.

Dr Lim Hui Xuan

Dr Lim Hui Xuan is Senior Lecturer at Department of Biomedical Sciences, ������Ƶ University. She has performed various laboratory experiments related to immune cells culture. During her postgraduate study at Korea University, she researched on the role of cytokines in cancer Immunotherapy, specifically on the differentiation and immunosuppressive activity of myeloid-derived suppressor cells. Dr Lim is currently studying the immunogenicity of mutated live-attenuated vaccines against enterovirus 71 (EV-A71).

Dr Say Yee How

Dr Say Yee How graduated with a 1st Class Honours Degree in Biomedical Science from Universiti Putra Malaysia in 2003 and was awarded the Royal Education Award by the Conference of Rulers Malaysia (Majlis Raja-raja). He went on to do a Ph.D. in Cell and Molecular Biology at University of Leeds, UK, on the cellular functions of prion protein, under the supervision of Prof. Nigel M. Hooper. Upon graduating in 2007, he was affiliated with University of Massachusetts Medical School, USA, Universiti Tunku Abdul Rahman (UTAR) Malaysia and National University of Singapore throughout his academic career. His research interests cover the fields of 3Ns in non-communicable diseases - Nutrigenetics, Neurodegeneration and Neoplasm. He has been actively conducting research and publishing journal articles in the field of genetic epidemiology of obesity and its related traits, taste sensory genetics (bitter, sweet, salty, umami, fatty), allergic diseases and various psychological conditions. He also researched on the pathophysiological roles of neuronal proteins (the Synucleins and cellular prion protein) in neuroprotection, neurodegeneration and cancer biology, as an attempt to shed light on the aetiologies of these diseases that afflict the ageing population. He also had the pleasure of serving the editorial board of the Journal of Physiological Anthropology.

Dr Ser Hooi Leng

Dr Ser Hooi Leng is currently a Lecturer at the Department of Biological Sciences, ������Ƶ University. She completed her Bachelor of Science (Molecular Biology & Biomedical Science) and Bachelor of Forensics (Forensic Biology) degrees at Murdoch University, Australia in 2012. Upon completing her undergraduate studies, she successfully secured a Summer Research Scholarship at the same university and had her first “taste” of research life, which piqued her interest in pursuing a career in biomedical science research. After returning to Malaysia, she began her postgraduate studies at Monash University. Her PhD project involves identifying novel Streptomyces species from mangrove forests and bioactivity screening of their secondary metabolites. Her research on the novel strain “Streptomyces malaysiense” with potent antioxidant and anticancer activities has garnered attention from the scientific community and she received TTLBF-YSPSAH Excellent Scientific Paper Award in 2016.

Her interest in microbiology research allows her to delve deeper into the intriguing world of bacteria, particularly in terms of understanding the relationship between microbes and human diseases. While microbes can be found practically everywhere, not all of them are harmful to humans. They could be employed as biomarkers for specific diseases and ailments, as well as pharmaceutical targets in treatments and prevention strategies. In addition to making discoveries in the lab, she actively builds and maintains research collaborations with scientists and doctors from both local and international institutions, hospitals, and organisations. Personally, she enjoys communicating with students and believes firmly in the power of communication. She wishes to help the younger minds to explore their interests in biomedical research and work together to make the world a better place for future generations.

��